US2013331344A1PendingUtilityA1
Learning motivation improvers
Est. expiryDec 25, 2029(~3.5 yrs left)· nominal 20-yr term from priority
A61P 3/04A61P 25/24A61P 25/00A61P 25/22A61P 25/20A61K 31/496A61K 38/12A61P 1/14A23V 2002/00A23L 33/18A61K 31/498A23L 2/52A61K 9/0053A23L 1/3053
53
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention aims to provide antidepressants which are free from the problem of side effects and are excellent in safety. The present invention also aims to provide learning motivation improvers which are useful for improvement of learning motivation and can be ingested continuously. The present invention provides antidepressants and learning motivation improvers, each comprising a cyclic dipeptide with the 2,5-diketopiperazine structure as an active ingredient.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method of treating depression comprising administering an effective amount of 2,5-piperazinedione,3,6-bis(phenylmethyl)-,(3S,6S) to a subject in recognized need thereof.
2 . The method according to claim 1 , wherein the administration is oral administration.
3 . The method according to claim 1 , wherein the 2,5-piperazinedione,3,6-bis(phenylmethyl)-,(3S,6S) is present in a food, beverage, tablet, capsule, powder, granule, solution, or elixir.
4 . The method according to claim 1 , wherein the 2,5-piperazinedione,3,6-bis(phenylmethyl)-,(3S,6S) is administered as a prophylactic and/or therapeutic agent for treatment of depression, senile depression symptoms, depressed mood, hypobulia, anxiety, or insomnia or anorexia associated with these symptoms.
5 . A method of treating depression comprising administering an antidepressant comprising an effective amount of one or more members selected from the group consisting of 2,5-piperazinedione,3,6-bis(phenylmethyl)-,(3S,6S); pyrrolo[1,2-a]pyrazine-1,4-dione,hexahydro-3-(1H-imidazol-4-ylmethyl)-,(3 S,8aS); pyrrolo[1,2-a]pyrazine-1,4-dione,hexahydro-3-(1H-indo1-3-ylmethyl)-,(3S,8aS); 2,5-piperazinedione,3,6-bis(1 H-indo1-3-ylmethyl)-,(3S,6S); pyrrolo[1,2-a]pyrazine-1,4-dione,hexahydro-3-(2-methylpropyl)-,(3S,8aS); and pyrrolo[1,2-a]pyrazine-1,4-dione,hexahydro-3-(1-methylethyl)-,(3S,8aS), to a subject in recognized need thereof.
6 . The method according to claim 5 , wherein the administration is oral administration.
7 . The method according to claim 5 , wherein the antidepressent is present in a food, beverage, tablet, capsule, powder, granule, solution, or elixir.
8 . The method according to claim 5 , wherein the antidepressant is administered as a prophylactic and/or therapeutic agent for treatment of depression, senile depression symptoms, depressed mood, hypobulia, anxiety, or insomnia or anorexia associated with these symptoms.
9 . A method for improving learning motivation comprising administering an effective amount of 2,5-piperazinedione,3,6-bis(phenylmethyl)-,(3S,6S) to a subject in recognized need thereof.
10 . The method according to claim 9 , wherein the administration is oral administration.
11 . The method according to claim 9 , wherein the 2,5-piperazinedione,3,6-bis(phenylmethyl)-,(3S,6S) is present in a food, beverage, tablet, capsule, powder, granule, solution, or elixir.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.